Recombinant human PI3K(p110alpha/p55gamma) protein (Active)
Be the first to review this product! Submit a review
|
(10 Publications)
Recombinant human PI3K(p110alpha/p55gamma) protein (Active) is a Human Full Length protein, expressed in Baculovirus infected Sf9 cells, with >70%, suitable for SDS-PAGE, WB, FuncS.
View Alternative Names
PI3-kinase subunit alpha, PI3K-alpha, PI3Kalpha, PtdIns-3-kinase subunit alpha, Phosphoinositide 3-kinase alpha, Phosphoinositide-3-kinase catalytic alpha polypeptide, Serine/threonine protein kinase PIK3CA, PtdIns-3-kinase subunit p110-alpha, p110alpha, PIK3CA, PI3-kinase subunit alpha, PI3K-alpha, PI3Kalpha, PtdIns-3-kinase subunit alpha, Phosphoinositide 3-kinase alpha, Phosphoinositide-3-kinase catalytic alpha polypeptide, Serine/threonine protein kinase PIK3CA, PtdIns-3-kinase subunit p110-alpha, p110alpha, PIK3CA
- FuncS
Supplier Data
Functional Studies - Recombinant human PI3K(p110alpha/p55gamma) protein (Active) (AB127617)
The specific activity of ab127617 was found to be 420 nmol/min/mg as per activity assay protocol.
- FuncS
Unknown
Functional Studies - Recombinant human PI3K(p110alpha/p55gamma) protein (Active) (AB127617)
The specific activity of PI3K(p110alpha/p55gamma) (ab127617) was determined to be 357 nmol/min/mg as per activity assay protocol
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant human PI3K(p110alpha/p55gamma) protein (Active) (AB127617)
SDS PAGE analysis of ab127617
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant human PI3K(p110alpha/p55gamma) protein (Active) (AB127617)
Purity >70% by densitometry.
p110alpha ~111kDa
p55gamma ~61kDa
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PI3Kα regulates cellular functions by participating in lipid phosphorylation at the 3-position of the inositol ring producing phosphatidylinositol (345)-trisphosphate (PIP3). This is an important event in recruiting signaling proteins with PH domains to the membrane leading to the activation of kinases like AKT. PI3Kα usually forms part of a complex with other proteins in order to facilitate its functions. This complex arrangement aids in mediating cell growth proliferation survival and metabolic responses making it a central player in cellular physiology.
Pathways
PI3Kα integrates into the PI3K/AKT/mTOR pathway a critical signaling cascade that controls myriad cellular processes. Within this pathway PI3Kα activates AKT which in turn interacts with downstream effectors like mTOR to regulate cellular metabolism and growth. PI3Kα also connects with proteins like PTEN and PDK1 to maintain a balance between cell survival and apoptosis. Besides this pathway influences glucose homeostasis and can affect various cellular states through intricate signaling networks.
Specifications
Form
Liquid
Additional notes
Affinity purified.
General info
Function
Phosphoinositide-3-kinase (PI3K) phosphorylates phosphatidylinositol (PI) and its phosphorylated derivatives at position 3 of the inositol ring to produce 3-phosphoinositides (PubMed : 15135396, PubMed : 23936502, PubMed : 28676499). Uses ATP and PtdIns(4,5)P2 (phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3) (PubMed : 15135396, PubMed : 28676499). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Participates in cellular signaling in response to various growth factors. Involved in the activation of AKT1 upon stimulation by receptor tyrosine kinases ligands such as EGF, insulin, IGF1, VEGFA and PDGF. Involved in signaling via insulin-receptor substrate (IRS) proteins. Essential in endothelial cell migration during vascular development through VEGFA signaling, possibly by regulating RhoA activity. Required for lymphatic vasculature development, possibly by binding to RAS and by activation by EGF and FGF2, but not by PDGF. Regulates invadopodia formation through the PDPK1-AKT1 pathway. Participates in cardiomyogenesis in embryonic stem cells through a AKT1 pathway. Participates in vasculogenesis in embryonic stem cells through PDK1 and protein kinase C pathway. In addition to its lipid kinase activity, it displays a serine-protein kinase activity that results in the autophosphorylation of the p85alpha regulatory subunit as well as phosphorylation of other proteins such as 4EBP1, H-Ras, the IL-3 beta c receptor and possibly others (PubMed : 23936502, PubMed : 28676499). Plays a role in the positive regulation of phagocytosis and pinocytosis (By similarity).
Sequence similarities
Belongs to the PI3/PI4-kinase family.
Target data
Additional targets
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Molecular vision 27:725-733 PubMed35035207
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 21:373 PubMed33732346
2021
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 12:507-515 PubMed33522374
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 21:1709-1716 PubMed32319634
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of experimental & clinical cancer research 38:410 PubMed31533855
2019
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 18:3543-3551 PubMed31602231
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cell proliferation 52:e12651 PubMed31297902
2019
Applications
Unspecified application
Species
Unspecified reactive species
Neuroscience bulletin 35:471-485 PubMed30684126
2019
Applications
Unspecified application
Species
Unspecified reactive species
Pathology, research and practice 215:115-120 PubMed30396754
2018
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 13:1097-104 PubMed26647768
2015
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com